# A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults

> **NCT05389319** · PHASE1 · RECRUITING · sponsor: **University Hospital Tuebingen** · enrollment: 96 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Prime-2-CoV_Beta

## Key facts

- **NCT ID:** NCT05389319
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-24
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05389319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05389319, "A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05389319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*